Overview
Radiation therapy plays a critical and evolving role in lung cancer treatment — from curative stereotactic body radiotherapy (SBRT) for early-stage disease, to concurrent chemoradiotherapy for locally advanced lung cancer, to palliative radiotherapy for advanced disease. At Shanghai's leading thoracic centers, precision radiation techniques combined with individualized treatment planning deliver world-class radiotherapy outcomes for international patients.
China Medical Concierge Shanghai (CMCS) connects international patients with Shanghai's top thoracic radiation oncologists, providing end-to-end support from remote consultation through to post-treatment follow-up.
Understanding Lung Cancer & the Role of Radiation
When Is Radiation Therapy Used in Lung Cancer?
Radiation therapy is used across the full spectrum of lung cancer management:
- Early-stage NSCLC (Stage I-II) — SBRT for patients who cannot undergo surgery; achieves local control rates comparable to surgical resection
- Locally advanced NSCLC (Stage III) — concurrent chemoradiotherapy (with or without immunotherapy consolidation) for unresectable disease; neoadjuvant chemoradiotherapy before surgery for selected resectable cases
- Brain metastases — stereotactic radiosurgery (SRS) for limited brain metastases; whole-brain radiotherapy (WBRT) for extensive brain involvement
- Bone and other metastases — palliative radiotherapy for pain control and local disease management
- Small cell lung cancer (SCLC) — thoracic radiotherapy combined with chemotherapy for limited-stage disease; prophylactic cranial irradiation (PCI)
Common Symptoms of Lung Cancer
- Persistent cough or haemoptysis
- Chest pain or shortness of breath
- Hoarseness and unexplained weight loss
- Recurrent respiratory infections
- Bone pain (metastatic disease)
- Neurological symptoms (brain metastases)
Precision Radiation Techniques for Lung Cancer
Stereotactic Body Radiotherapy (SBRT)
SBRT delivers very high doses of precisely targeted radiation in a small number of fractions (typically 3–5 treatments). For early-stage NSCLC in patients who cannot undergo surgery — due to poor lung function, cardiac disease, or other comorbidities — SBRT achieves local control rates of 90–95% at 3 years, comparable to surgical resection. SBRT is also used for oligometastatic disease — limited metastatic lesions in the lung, liver, adrenal glands, or bone.
Intensity-Modulated Radiation Therapy (IMRT) & Volumetric Modulated Arc Therapy (VMAT)
IMRT and VMAT are advanced radiation delivery techniques that precisely shape the radiation dose to the tumor while minimizing exposure to surrounding critical structures — including the healthy lung, heart, spinal cord, and esophagus. These techniques are the standard for locally advanced lung cancer treatment, enabling higher tumor doses with lower toxicity compared to conventional radiotherapy.
4D-CT Motion Management
The lung moves with breathing, which can cause the tumor to shift during radiation delivery. 4D-CT motion management — including respiratory gating and breath-hold techniques — accounts for this motion, ensuring that radiation is delivered precisely to the tumor throughout the breathing cycle and reducing the risk of geographic miss or unnecessary normal tissue irradiation.
Stereotactic Radiosurgery (SRS) for Brain Metastases
For patients with lung cancer and limited brain metastases, SRS delivers a single high dose of precisely targeted radiation to each metastasis, achieving excellent local control while preserving neurocognitive function — an important advantage over whole-brain radiotherapy.
Concurrent Chemoradiotherapy for Stage III NSCLC
For unresectable stage III NSCLC, concurrent chemoradiotherapy (platinum-based chemotherapy + IMRT/VMAT) followed by consolidation immunotherapy (durvalumab, the PACIFIC regimen) is the current standard of care, offering the best chance of long-term disease control.
Why Choose Shanghai Chest Hospital for Lung Cancer Radiotherapy?
- China's premier dedicated thoracic disease center — Shanghai Chest Hospital is one of China's largest and most specialized hospitals for lung and thoracic conditions
- Advanced precision radiotherapy technology — SBRT, IMRT, VMAT, 4D-CT motion management, and SRS all available on-site
- Multidisciplinary integration — radiation oncology fully integrated with thoracic surgery, medical oncology, and supportive care
- Individualized treatment planning — radiotherapy precisely tailored to each patient's tumor anatomy, lung function, and clinical situation
- Cost-effective world-class care — significantly lower cost than equivalent treatment in the US, UK, or Singapore
Featured Specialist: Dr. Cai Xuwei — Shanghai Chest Hospital
Dr. Cai Xuwei (蔡旭伟) is an Associate Chief Physician of Radiation Oncology at Shanghai Chest Hospital — China's premier dedicated thoracic disease center. He specializes in precision radiotherapy and individualized comprehensive treatment for lung cancer and other thoracic tumors.
Precision Radiotherapy Expertise
Dr. Cai's clinical focus is the delivery of precision radiation therapy for thoracic malignancies — using advanced techniques including SBRT, IMRT, VMAT, and 4D-CT motion management to achieve the highest possible tumor control rates while minimizing radiation toxicity. His expertise in individualized treatment planning ensures that each patient's radiotherapy is precisely tailored to their tumor anatomy, lung function, and overall clinical situation.
Individualized Comprehensive Treatment
Beyond radiotherapy alone, Dr. Cai's approach integrates radiation with chemotherapy, targeted therapy, and immunotherapy in a coordinated, individualized comprehensive treatment plan. This multidisciplinary perspective — understanding how radiation interacts with systemic therapies and how to sequence treatments for optimal outcomes — is essential for achieving the best results in lung cancer management.
Clinical Expertise
- SBRT for early-stage and oligometastatic lung cancer — high-dose precision radiotherapy for inoperable early-stage NSCLC and limited metastatic disease
- IMRT/VMAT for locally advanced lung cancer — concurrent chemoradiotherapy for stage III NSCLC
- SRS for brain metastases — stereotactic radiosurgery for limited brain involvement
- 4D-CT motion management — respiratory gating and breath-hold techniques for precise tumor targeting
- Individualized comprehensive treatment planning — radiation integrated with chemotherapy, targeted therapy, and immunotherapy
- Other thoracic tumors — thymoma, mesothelioma, and other thoracic malignancies
For international patients, Dr. Cai's team offers remote pre-consultation review of CT scans, PET-CT, brain MRI, and pathology, enabling a precise radiotherapy plan to be developed before arrival in Shanghai.
How CMCS Supports Your Journey
CMCS is not a hospital — we are your dedicated medical concierge, providing a trusted bridge between international patients and Shanghai's finest cancer specialists.
Our services include:
- ✅ Direct appointment coordination with Dr. Cai Xuwei and the Shanghai Chest Hospital radiation oncology team
- ✅ CT, PET-CT, brain MRI, and pathology translation and pre-consultation review
- ✅ Second opinion facilitation
- ✅ Treatment scheduling and hospital coordination support
- ✅ Accommodation and logistics coordination in Shanghai
- ✅ Post-treatment follow-up and remote check-in support
Contact CMCS
If you or a loved one has been diagnosed with lung cancer and would like to explore precision radiation therapy options in Shanghai, our team is ready to help.
📧 Email: contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 Website: www.medicalsh.com
CMCS — China Medical Concierge Shanghai. Connecting international patients with Shanghai's finest specialists.
0件のコメント